| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acknowledgements
|
|
|
2018
|
67 |
3 |
p. 507-511
|
article
|
| 2 |
Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expression as a means for tissue quality screening
|
Zhang, Xu-chao
|
|
2017
|
67 |
3 |
p. 471-481
|
article
|
| 3 |
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors
|
Mehla, Kamiya
|
|
2017
|
67 |
3 |
p. 445-457
|
article
|
| 4 |
Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC
|
Becker, Jürgen C.
|
|
2017
|
67 |
3 |
p. 341-351
|
article
|
| 5 |
Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells
|
Bachanova, Veronika
|
|
2017
|
67 |
3 |
p. 483-494
|
article
|
| 6 |
High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer
|
Okuma, Yusuke
|
|
2017
|
67 |
3 |
p. 495-505
|
article
|
| 7 |
High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients
|
Breyer, Johannes
|
|
2017
|
67 |
3 |
p. 403-412
|
article
|
| 8 |
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody
|
Suh, Koung Jin
|
|
2017
|
67 |
3 |
p. 459-470
|
article
|
| 9 |
Prophylactic DNA vaccine targeting Foxp3+ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model
|
Namdar, Afshin
|
|
2017
|
67 |
3 |
p. 367-379
|
article
|
| 10 |
Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737
|
Noll, Theresa
|
|
2017
|
67 |
3 |
p. 413-422
|
article
|
| 11 |
Targeting and suppression of HER3-positive breast cancer by T lymphocytes expressing a heregulin chimeric antigen receptor
|
Zuo, Bai-Le
|
|
2017
|
67 |
3 |
p. 393-401
|
article
|
| 12 |
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy
|
Briere, David
|
|
2017
|
67 |
3 |
p. 381-392
|
article
|
| 13 |
The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases
|
Wang, Yun
|
|
2017
|
67 |
3 |
p. 435-444
|
article
|
| 14 |
Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome
|
Geskin, Larisa J.
|
|
2017
|
67 |
3 |
p. 423-434
|
article
|
| 15 |
Tumor-derived high-mobility group box 1 and thymic stromal lymphopoietin are involved in modulating dendritic cells to activate T regulatory cells in a mouse model
|
Zhang, Yi
|
|
2017
|
67 |
3 |
p. 353-366
|
article
|
Journal description